27 januari, 2025 Icke-regulatoriskt Promising results from AcuCort’s Phase IV study – scientific articles under preparation for international publication
17 januari, 2025 Regulatoriskt AcuCort's Chairman subscribes for an additional approximately SEK 200,000 in the ongoing rights issue
14 januari, 2025 Regulatoriskt AcuCort’s CEO subscribes for an additional SEK 1 million in the ongoing rights issue, bringing total commitment to approximately SEK 2 million